2,729
Views
4
CrossRef citations to date
0
Altmetric
Dermatology

Modeling the optimal sequence of biologic therapies in plaque psoriasis in Spain

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1134-1142 | Received 21 Jun 2021, Accepted 18 Aug 2021, Published online: 25 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nanna Nyholm, Anne Danø, Henrik Schnack & Giorgio Lorenzo Colombo. (2023) The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis. ClinicoEconomics and Outcomes Research 15, pages 607-619.
Read now
Nanna Nyholm, Henrik Schnack, Anne Danø & François Skowron. (2023) Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany. Current Medical Research and Opinion 39:6, pages 833-842.
Read now

Articles from other publishers (2)

Jaroslav Duda. (2022) Cost-effectiveness analysis of biological drugs in treating moderate to severe plaque psoriasis from the perspective of a health service provider. Klinická farmakologie a farmacie 36:2, pages 54-67.
Crossref
V. D. Sokolova, N. A. Sableva, V. V. Mladov & D. G. Tolkacheva. (2022) Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15:1, pages 131-144.
Crossref